Skip to main content
    A

    AngioDynamics Inc (ANGO)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $11.87
    -0.11 (-0.96%)

    Market Cap: $499.19M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    AngioDynamics Inc (ANGO) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    AngioDynamics (ANGO) trades at 1.5x sales and 3.0x book value. Its P/S of 1.5x is above its 5-year median of 1.4x. Its forward P/E is 96.2x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E96.2x
    Price to sales1.5x
    Price to book3.0x
    PEGN/A
    FCF yield-0.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 11.8% below 1.7x and its P/B is 114.3% above 1.4x.

    MultipleCurrent5-year median10-year median
    P/S1.5x1.4x1.7x
    P/B3.0x1.9x1.4x
    Medians of month-end values through Oct 2026: 58 to 60 months (5-year) and 118 to 120 months (10-year).

    Valuation History

    Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 24.1x in 2016 to 27.6x in 2019. 2019 was the highest of those years.

    Year endPriceP/EP/SP/B
    2025$12.84N/A1.7x3.0x
    2024$9.16N/A1.3x2.0x
    2023$7.84N/A0.9x0.8x
    2022$13.77N/A1.6x1.3x
    2021$27.58N/A3.5x2.5x
    2020$15.33N/A2.2x1.3x
    2019$16.0127.6x2.2x1.0x
    2018$20.1324.3x3.4x1.4x
    2017$16.6325.2x2.3x1.2x
    2016$16.8724.1x1.7x1.2x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ANGO

    What is ANGO's forward P/E ratio?

    AngioDynamics has a forward P/E ratio of 96.2x.

    Is ANGO stock overvalued?

    GNG's valuation label for ANGO is Fairly valued.

    What is ANGO's price to sales ratio?

    AngioDynamics has a price to sales ratio of 1.5x.